abstract |
The present invention relates to viral vectors and in particular to adeno-associated viral vectors with enhanced gene transfer capabilities into cells of the central nervous system (CNS). The invention has been developed primarily for gene transfer in glial cells and further for the treatment of diseases associated with glial cell pathology. |